Search research articles
Contact Us
Filters
Showing results (751-760 of 945) with videos related to
Page
of 95
Sort By:
Nature Reviews. Microbiology
|
October 14, 2021
Infectious disease in an era of global change
Rachel E Baker, Ayesha S Mahmud, Ian F Miller, et al.
The Lancet. Oncology
|
March 28, 2024
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
Rachel M Layman, Hyo S Han, Hope S Rugo, et al.
Plos One
|
March 21, 2024
Late shellmound occupation in southern Brazil: A multi-proxy study of the Galheta IV archaeological site
Jessica Mendes Cardoso, Fabiana Merencio, Ximena Villagran, et al.
Nature Biotechnology
|
April 1, 1997
FP-21399 blocks HIV envelope protein-mediated membrane fusion and concentrates in lymph nodes
M Ono, Y Wada, Y Wu, et al.
Oral Oncology
|
December 20, 2023
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study
Renata Ferrarotto, Paul L Swiecicki, Dan P Zandberg, et al.
Vaccine
|
December 3, 2019
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
F T Cutts, E Dansereau, M J Ferrari, et al.
Frontiers in Oncology
|
April 10, 2026
Case Report: Late choroidal metastasis from hormone receptor-positive, HER2-negative breast cancer responsive to first-line endocrine therapy
Hisham Alsharif, Robert Wesolowski, Colleen M Cebulla, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2007
Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core
Joël Robichaud, Christopher I Bayly, W Cameron Black, et al.
Nature Communications
|
October 1, 2020
The use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology
Kyra H Grantz, Hannah R Meredith, Derek A T Cummings, et al.
Investigational New Drugs
|
February 24, 2021
LY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial
Afshin Dowlati, R Donald Harvey, Richard D Carvajal, et al.
Page
of 95
Search research articles
Search
Showing results (751-760 of 945) with videos related to
Sort By:
Page
of 95
Nature Reviews. Microbiology
|
October 14, 2021
Infectious disease in an era of global change
Rachel E Baker, Ayesha S Mahmud, Ian F Miller, et al.
The Lancet. Oncology
|
March 28, 2024
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
Rachel M Layman, Hyo S Han, Hope S Rugo, et al.
Plos One
|
March 21, 2024
Late shellmound occupation in southern Brazil: A multi-proxy study of the Galheta IV archaeological site
Jessica Mendes Cardoso, Fabiana Merencio, Ximena Villagran, et al.
Nature Biotechnology
|
April 1, 1997
FP-21399 blocks HIV envelope protein-mediated membrane fusion and concentrates in lymph nodes
M Ono, Y Wada, Y Wu, et al.
Oral Oncology
|
December 20, 2023
PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study
Renata Ferrarotto, Paul L Swiecicki, Dan P Zandberg, et al.
Vaccine
|
December 3, 2019
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
F T Cutts, E Dansereau, M J Ferrari, et al.
Frontiers in Oncology
|
April 10, 2026
Case Report: Late choroidal metastasis from hormone receptor-positive, HER2-negative breast cancer responsive to first-line endocrine therapy
Hisham Alsharif, Robert Wesolowski, Colleen M Cebulla, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 6, 2007
Beta-substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core
Joël Robichaud, Christopher I Bayly, W Cameron Black, et al.
Nature Communications
|
October 1, 2020
The use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology
Kyra H Grantz, Hannah R Meredith, Derek A T Cummings, et al.
Investigational New Drugs
|
February 24, 2021
LY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial
Afshin Dowlati, R Donald Harvey, Richard D Carvajal, et al.
Page
of 95